病理性二硫化物键交叉连接:分子洞察氨基代和疾病进展的分子洞察力
Yun Kyung Kim1, Dong Min Kang2, Nataliia Lukianenko2
1Korea Institute of Science and Technology, Brain Science Institute, Sungbukgu haworkgokdong, 02792, Seoul, KOREA, REPUBLIC OF.
Chembiochem : a European journal of chemical biology
|June 10, 2025
概括
双硫化物交联稳定了错误折叠的蛋白质,在神经退行症等疾病中促进了粉样纤维的形成. 了解这一过程,揭示了粉样粉症的新治疗点.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 病理学 病理学 病理学
背景情况:
- 粉样蛋白生成涉及蛋白质错误折叠和聚合成粉样纤维.
- 这一过程与神经退行性疾病和全身性氨基粉症有关.
- 双硫化物交联因其在稳定蛋白质聚合物的作用而越来越被认可.
研究的目的:
- 检查异常二硫化物键形成的细胞路径.
- 检查二硫化物交叉链接对疾病进展的影响.
- 为了突出显示二硫化物交联的寡合体作为粉样纤维的前体.
主要方法:
- 关于细胞通路的文献综述.
- 在蛋白质聚合中对二硫化键形成的分析.
- 讨论通过二硫化物交叉连接物种破坏蛋白质稳定性的讨论.
主要成果:
- 双硫化物交叉链稳定了错误折叠的蛋白质中间体.
- 异常的二硫化物键有助于粉样蛋白的发病.
- 双硫化物交叉连接的寡合体抵抗降解,并促进纤维细胞的形成.
结论:
- 二硫化物交叉连接是粉样蛋白形成的关键因素.
- 针对二硫化物键路径提供了潜在的治疗策略.
- 了解二硫化物交叉链接可以提高对粉样蛋白疾病的洞察力.
更多相关视频
09:37Combining Non-reducing SDS-PAGE Analysis and Chemical Crosslinking to Detect Multimeric Complexes Stabilized by Disulfide Linkages in Mammalian Cells in Culture
Published on: May 2, 2019
10.0K
00:15Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils
Published on: September 28, 2019
5.9K
相关概念视频
Amyloid Fibrils
9.3K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.3K
Alzheimer's Disease: Overview
451
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
451
